Please login to the form below

vilaprisan

This page shows the latest vilaprisan news and features for those working in and with pharma, biotech and healthcare.

Bayer moves vilaprisan into phase III trials for uterine fibroids

Bayer moves vilaprisan into phase III trials for uterine fibroids. ASTEROID study will investigate safety and efficacy of the novel drug. ... Bayer is beginning late-stage trials of vilaprisan, its novel oral, selective progesterone receptor modulator

Latest news

Xarelto and Eylea continue to dominate Bayer's pharma sales

They include five candidates in phase III trials: copanlisib for non-Hodgkin lymphoma, ODM-201 for hormone-sensitive prostate cancer, finerenone for diabetic kidney disease, vilaprisan for uterine fibroids and endriametosis
Allergan plans to file oral uterine fibroid drug in US by year-end

Other companies working on new therapies for uterine fibroids include Bayer, which has a candidate called vilaprisan in mid-stage clinical development.
Allergan on course to file uterine fibroid drug next year

Other companies working on new therapies for uterine fibroids include Bayer, which has a candidate called vilaprisan in mid-stage clinical development.
Bayer puts research at heart of business growth

The other two drugs touted to advance to phase III are copanlisib for non-Hodgkin's lymphoma and vilaprisan to treat symptomatic uterine fibroids – begin tumours that form in the uterus. “

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Featured jobs

Account Director, Healthcare Communications Agency: £54, 000- £60, 000

Deputy Managing Director – Healthcare PR – Global Agency: Negotiable

Senior Writer, Healthcare Advertising, London: Excellent package

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Senior Medical Writer, Principal Medical Writer, Scientific Dire...: £40000 - £75000 Bonus Benefits

Account Manager- 4 days per week or full-time: Salary TBC

Head of Market Access - International - Based Cambridge: Excellent Basic, Bonus and Flex Benefits

Integrated Brand/ Digital Senior Account Director, London: Excellent package

Associate Scientific Director: Salary TBC

Account Manager, Healthcare Advertising: £30 - 38, 000 (or -)

Medical Writer - Creative and Scientific Projects: DOE

Sudler London - Senior Medical Writer: Competitive

Account Manager, MedicalCommunications/ Healthcare PR: benefits

Senior/ Market Access Consultant, UK, HOME BASED, £50-60K: Excellent package

Leadership opportunity, Pricing & Market Access, UK, Substan...: Substantial six figure package

Account Director - Award Winning Healthcare Advertising Agency -...: £50000 - £68000

Senior Medical Writer, MedComms Agency: £40 - 55, 000 according to skills and experience benefits

Healthcare PR Senior Account Manager: Salary TBC

Account Director or Senior Account Director: Salary TBC

Market Access Consultant - Greater Manchester: Negotiable

Digital Account Director – Health/ Pharma – Global Agency: Salary TBC

Technical Manager – Developer and Commercial Excellence, Healthc...: Excellent package

Account Director, Healthcare Advertising Agency: Salary TBC

Account Manager: Negotiable

Principal Medical Writer / Editorial Director – Medical Communic...: £60, 000 - £80, 000

Subscribe to our email news alerts

PMHub

Add my company

W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

PM Society Digital Awards – the power of together: Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduce anyone in four simple steps: You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government: GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....